FIELD: medicine, pharmacy.
SUBSTANCE: invention proposes using mirtazapine as a medicinal agent in treatment of primary insomnia and a corresponding method for treatment. Medicinal agent comprises from 0.1 to 5 mg of mirtazapine (in paricular, S-mirtazapine) taken in the standard dose. Invention shows a low dose of mirtazapine for inducing sleep and improvement of sleep quality in the primary insomnia.
EFFECT: valuable medicinal properties of drug.
6 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING INSOMNIA | 2002 |
|
RU2560840C2 |
| USE OF AN INVERSE AGONIST H3R FOR TREATING SLEEP DISORDER IN SHIFT WORK | 2018 |
|
RU2768894C2 |
| COMPOSITIONS AND METHODS FOR TREATING INSOMNIA | 2015 |
|
RU2703297C2 |
| METHODS FOR USING CYCLIC AMIDE DERIVATIVES FOR TREATING SCHIZOPHRENIA | 2011 |
|
RU2576611C2 |
| MELATONIN AGONIST THERAPY | 2007 |
|
RU2488392C2 |
| APPLICATION OF COMPOUND FOR TREATING SLEEP DISORDERS, FOR PROVIDING THE STATE OF CHEERFULNESS AFTER AWAKENING AND METHOD FOR TREATING THE STATE OF DEPRESSION | 2002 |
|
RU2320340C2 |
| TREATING SLEEP DISTURBANCES | 2008 |
|
RU2483733C2 |
| METHODS FOR TREATMENT OF DISORDERS OF CIRCADIAN SLEEP RHYTHM | 2017 |
|
RU2763493C2 |
| APPLICATION OF TRIPROLIDINE TO ENSURE VIVACITY IN AWAKENING | 2004 |
|
RU2372915C2 |
| METHODS FOR TREATING AND PREVENTING FATIGUE | 2010 |
|
RU2567801C2 |
